UBS On-Air: Market Moves

Inside Washington DC the current focus seems to be trade tariffs, although the affordability crisis continues to be the focus in the wider economy. US President Trump suggested US consumers of imported generic pharmaceuticals would have to pay a 100% tariff from August 2027, and 200% from August 2029. The US has notably higher health care costs relative to developed European economies, and such a cost would add further to US prices.

Join Jeremy Zirin, Senior Portfolio Manager of the House View Equity Portfolios and Head of the Private Client US Equity Team with UBS Asset Management, as he shares a performance update for US equities. Host: Dominic Schagar, Senior Equity Investment Specialist. Recorded on 15.07.26

US President Trump threatened to impose a 50% tariff on US importers of products from Canada, without exempting products covered by the latest iteration of the NAFTA trade deal. If implemented, the tax would probably push up US consumer prices quite quickly. However, markets offered a muted response—the Canadian dollar and US inflation-linked bonds remaining relatively calm. Investors seem inclined to discount or dismiss such threats.

As investors now operate within the AI economy, Jason Draho, Head of Asset Allocation Americas and Paul Hsiao, Senior Asset Allocation Strategist Americas, from the UBS Chief Investment Office, join to share a framework on how to navigate it. We also discuss how to assess the economic impacts of AI, along with a look at portfolio construction through an AI lens. Host: Daniel Cassidy

Semiconductors have seen a drop over the past month, raising the question of whether markets are starting to price in a real AI glut or simply reassessing a powerful rally. This episode explores why AI demand may prove more resilient than the recent sell-off suggests, where the real constraints are emerging across the infrastructure stack, and what that could mean for semiconductor stocks from here.